Blog - INTERNET MÉDICA

■ EAU-ESMO consensus statements on the management of advanced and variant bladder cancer – an international collaborative multi-skateholder effort: under the auspices of the EAU and ESMO guidelines committest

A Horwing, M Babjuk, J Bellmunt et al

Ann Oncol 2019, vol 30 (11): 1697-1727

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360152/

■ Current topics in radiotherapy for genitourinary cancers: Consensus statements of the genitourinary radiation oncologists of Canada

Scott C. Morgan, Gerard C. Morton, Alejandro Berlin, et al

Can Urol Assoc J. 2020 Nov; 14(11): E588–E593

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673835/

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: maio 2021

Hipertrofia Prostática Benigna: Artigos de Revisão (Benign Prostatic Hyperplasia: Reviews)

Por Paulo Leite 03/05/2021

■ A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatment for benign prostatic hyperplasia: impact on erectile and ejaculatory domains

Brian Hung Shin Ng, Eric Chung

Investig Clin Urol. 2021 Mar; 62(2): 148–158

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940857/

■ Current treatment for benign prostatic hyperplasia

Arkadiusz Miernik, Christian Gratzke

Dtsch Arztebl Int. 2020 Dec; 117(49): 843–854

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021971/

■ Clinical predictive factors in prostatic artery embolization for symptomatic bening prostatic hyperplasia: a comprehensive review

Fei Sun, Vanesa Lucas-Cava, Francisco Miguel Sánchez-Margallo

Transl Androl Urol. 2020 Aug; 9(4): 1754–1768

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475690/

■ Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain

José María Molero, Bernardino Miñana, Juan Manuel Palacios‐Moreno et al

Int J Clin Pract. 2020 Nov; 74(11): e13602

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685138/

■ Biomarkers that differentiate benign prostatic hyperplasia from prostate cancer: a literature review

Christopher J McNally, Mark W Ruddock, Tara Moore, et al

Cancer Manag Res. 2020; 12: 5225–5241.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335899/

■ Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: systematic review and meta-analysis

Larry E. Miller, Bilal Chughtai, Kevin McVary, et al

Medicine (Baltimore) 2020 Jul 24; 99(30): e21365

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387023/

■ An update on minimally invasive surgery for benign prostatic hyperplasia> techniques, risks, and efficacy

Aditya Srinivasan, Run Wang

World J Mens Health. 2020 Oct; 38(4): 402–411

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502324/

■ Modern best practice in the management of benign prostatic hyperplasia in the elderly

Eric Bortnick, Conner Brown, Vannita Simma-Chiang, Steven A. Kaplan

Ther Adv Urol. 2020 Jan-Dec; 12: 1756287220929486

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273551/

■ Tratamiento quirúrgico de la hiperplasia prostática benigna: Revisión de la literatura

López-Ramos, Hugo et al.

Rev. mex. urol., Oct 2019, vol.79, no.5

http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2007-40852019000500009&lng=es&nrm=iso

■ Low-term consequences of medical therapy for benign prostatic hyperplasia

Eric M. Bortnick, Vannita Simma-Chiang, Steven A. Kaplan

Rev Urol. 2019; 21(4): 154–157.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020283/